It has been alternatively called cranial arteritis or temporal arteritis, reflecting the most commonly affected vessels. However, this terminology minimizes the systemic nature of this vasculitis ...

Patients with predominantly cranial vs isolated extracranial GCA phenotypes present with different patterns of arterial involvement on 18F-FDG PET-CT scans.

AbbVie’s Rinvoq (upadacitinib) has been granted marketing authorisation by the European Commission (EC) to treat giant cell ...

The European Commission (EC) has granted marketing authorisation for AbbVie's once-a-day treatment Rinvoq (upadacitinib) 15mg ...

Visual loss is the most feared complication in temporal arteritis ... by acute and/or chronic manifestations of cranial and large vessel arteritis and aortitis, leading to blindness, development ...

Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...

Find effective medications for 'Temporal Arteritis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...